|
Office of Biotechnology Activities
|
National Institutes of Health - Office of Science Policy
|
| |
| Clinical Utility and Comparable Effectiveness of Genetic Testing Information |
|
 |
|
|
|
|
|
|
|
|
| |
|
|
SACGHS Meetings |
|
| |
|
|
|
Thursday, February 4, 2010 - Clinical Utility and Comparative Effectiveness Updates |
|
| |
|
| |
Update on the Clinical Utility and Comparative Effectiveness Task Force |
|
|
| |
Marc Williams, M.D., SACGHS Member
|
|
|
| |
Transcript
|
|
|
| |
Slides
|
|
|
| |
|
|
Friday, June 12, 2009 - Future of Clinical Utility and Comparative Effectiveness |
|
| |
|
| |
Clinical Effectiveness, Clinical Utility, Comparative Effectiveness: An Evolving Landscape |
|
|
| |
Gurvaneet Randhawa, M.D., M.P.H., Agency for Healthcare Research and Quality
|
|
|
| |
Slides
|
|
|
| |
Future Directions and the Role of Genomics in Comparative Effectiveness |
|
|
| |
Harold Sox, M.D., M.A.C.P., Chair, Institute of Medicine Committee on Comparative Effectiveness Research Prioritization
|
|
|
| |
Slides
|
|
|
| |
Role of Genomics in Comparative Effectiveness Research, National Institute of Health Perspective |
|
|
| |
Michael Lauer, M.D., Director, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH
|
|
|
| |
Future Directions and Developments in Research Methodologies |
|
|
| |
Steven Goodman, M.D., M.H.S., Ph.D., Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
|
|
|
| |
Impact of Comparative Effectiveness Findings on Clinical Practice |
|
|
| |
Marc Williams, M.D., SACGHS Member
|
|
|
| |
Slides
|
|
|
| |
Committee Discussion |
|
|
| |
Transcript
|
|
|
|
|
|
|